Amarin’s fish-oil drug approved to prevent heart attacks and strokes – STAT
The FDA expanded the approval of Vascepa to allow Amarin to say it prevents heart attacks and strokes in people who are at high cardiovascular risk.
The FDA expanded the approval of Vascepa to allow Amarin to say it prevents heart attacks and strokes in people who are at high cardiovascular risk.
Single Dose of BEAM-302 Led to Durable, Dose-dependent Increases in Total and Functional Alpha-1 Antitrypsin (AAT), Production of Corrected M-AAT, and…
The abstract submission is now open!
Patients with advanced kidney cancer who received an experimental vaccine after their tumors were removed were still cancer-free years later in a small early-stage trial,…
All nine late-stage kidney cancer patients in a Phase 1 trial of a personalized vaccine remained cancer-free after more than three years of receiving treatment,…
All nine patients treated at Dana-Farber Cancer Institute in a phase 1 trial of a personalized cancer vaccine for patients with stage III or IV…
With novel radiopharmaceutical therapies entering clinical trials and into clinical practice, the 2025 Transatlantic Exchange in Oncology will focus on bringing together key experts from…
Renowned radiation oncologist Felix Y. Feng, MD, passed away from cancer on Dec. 10, 2024, at the age of 48.
About the Oncology Center of Excellence
While the announcement is good news for the Princess of Wales, cancer experts describe the challenges of a life shadowed by an earlier diagnosis.
While the announcement is good news for the Princess of Wales, cancer experts describe the challenges of a life shadowed by an earlier diagnosis.